Proceedings: Human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the california population: Evaluating matching in a multiethnic and admixed population

Stem Cells Translational Medicine

Volumn 4, Issue 5, 2015, Pages 413-418

  Pappas, Derek James ^a,b   Gourraud, Pierre Antoine ^a,c,d   Le Gall, Caroline ^a,c   Laurent, Julie ^a,c   Trounson, Alan ^e,f   DeWitt, Natalie ^e,f,g   Talib, Sohel ^e  

^a Methodomics Mortagne sur Sevre ^*  (France)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c The Higher Institute of Biotechnologies of Paris   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e California Institute for Regenerative Medicine   (United States)

^f MONASH MEDICAL CENTRE   (Australia)

^g STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DRB1 ANTIGEN; HLA ANTIGEN;

ARTICLE; CIS AND TRANS MATCHING; ETHNICITY; GENOTYPE; HAPLOBANK; HAPLOTYPE; HEALTH CARE FACILITY; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; RACE; SIMULATION; UNITED STATES; CELL LINE; CYTOLOGY; DONOR; ETHNIC GROUP; GENETICS; HISTOCOMPATIBILITY TEST; HOMOZYGOTE; POPULATION GENETICS; STEM CELL RESEARCH;

CALIFORNIA; CELL LINE; ETHNIC GROUPS; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HOMOZYGOTE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; STEM CELL RESEARCH; TISSUE DONORS;

EID: 84930431464     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2015-0052     Document Type: Article

References (22)

1. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861–872.
2. Takahashi K, Yamanaka S. Induction of plu-ripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–676.
3. Charron D. Allogeni city& immunogenicity in regenerative stem cell therapy. Indian J Med Res 2013;138:749–754.
4. Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripo-tent stem cells. J Clin Invest 2010;120:51–59.
5. Lui KO, Waldmann H, Fairchild PJ. Embryonic stem cells: Overcoming the immunological barriers to cell replacement therapy. Curr Stem Cell Res Ther 2009;4:70–80.
6. Taylor CJ, Bolton EM, Pocock S et al. Banking on human embryonic stem cells: Estimating the number of donor cell lines needed for HLA matching. Lancet 2005;366:2019–2025.
7. Gourraud PA, Gilson L, Girard M et al. The role of human leukocyte antigen matching in the development of multiethnic “haplobank” of induced pluripotent stem cell lines. Stem Cells 2012;30:180-186.
8. Gragert L, Madbouly A, Freeman J et al. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum Immunol 2013;74:1313-1320.
9. U.S. Census Bureau. State & County Quick-Facts: California. Available at: http://quickfacts.census.gov/qfd/states/06000.html. Accessed April 30, 2014.
10. Eberhard HP, Madbouly AS, Gourraud PA et al. Comparative validation of computer programs for haplo type frequency estimation from donor registry data. Tissue Antigens 2013;82: 93-105.
11. Maiers M, Gragert L, Mad bouly A et al. 16 (th) IHIW: Global analysis of registry HLAhaplo-types from 20 million individuals: Report from the IHIW Registry Diversity Group. Int J Immu-nogenet 2013;40:66-71.
12. Fallin D, Schork NJ. Accuracyofhaplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000;67:947–959.
13. Gourraud PA, Génin E, Cambon-Thomsen A. Handling missing values in population data: Consequences for maximum likelihood estimation of haplo type frequencies. Eur J Hum Genet 2004;12:805–812.
14. Gourraud PA, Lamiraux P, El-Kadhi N et al. Inferred HLA haplotype information for donors from hematopoietic stem cells donor registries. Hum Immunol 2005;66:563–570.
15. Pappas DJ, Tomich A, Garnier F et al. Comparison of high-resolution human leukocyte antigen haplotype frequencies in different ethnic groups: Consequences of sampling fluctuation and haplotype frequency distribution tail truncation. Hum Immunol 2015 [Epub ahead of print].
16. Petersdorf EW. Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 2008;20:588–593.
17. Shaw BE, Arguello R, Garcia-Sepulveda CA et al. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation. Br J Haematol 2010; 150:251-258.
18. Warren EH, Zhang XC, Li S et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood 2012;120:2796-2806.
19. Spierings E. Minor histocompatibility antigens: Past, present, and future. Tissue Antigens 2014;84:347-60.
20. Charron D, Suberbielle-Boissel C, Al-Daccak R. Immunogenicity and allogenicity: A challenge of stem cell therapy. J Cardiovasc Transl Res 2009;2:130-138.
21. Scheiner ZS, Talib S, Feigal EG. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies. J Biol Chem 2014;289:4571-4577.
22. Ruggeri A, Ciceri F, Gluckman E et al. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploident-ical donors? Best Pract Res Clin Haematol 2010;23:207-216.